Annual SG&A
$16.98 M
+$2.43 M+16.73%
30 June 2022
Summary:
Applied Genetic Technologies annual selling, general & administrative expenses is currently $16.98 million, with the most recent change of +$2.43 million (+16.73%) on 30 June 2022. During the last 3 years, it has risen by +$2.43 million (+16.73%).AGTC Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$4.46 M
-$15.00 K-0.34%
30 September 2022
Summary:
Applied Genetic Technologies quarterly selling, general & administrative expenses is currently $4.46 million, with the most recent change of -$15.00 thousand (-0.34%) on 30 September 2022.AGTC Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.20 B
-$70.23 M-6.22%
30 September 2022
Summary:
Applied Genetic Technologies TTM selling, general & administrative expenses is currently -$1.20 billion, with the most recent change of -$70.23 million (-6.22%) on 30 September 2022.AGTC TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGTC Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +16.7% | +8.8% | -7988.2% |
| 5 y5 years | +32.1% | +33.2% | -9336.5% |
AGTC Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | at high | -0.3% | -7019.5% |
Applied Genetic Technologies Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $4.46 M(-0.3%) | $17.34 M(+2.1%) |
| June 2022 | $16.98 M(+16.7%) | $4.47 M(+1.2%) | $16.98 M(+1.1%) |
| Mar 2022 | - | $4.42 M(+10.8%) | $16.79 M(+5.6%) |
| Dec 2021 | - | $3.99 M(-2.7%) | $15.90 M(+4.5%) |
| Sept 2021 | - | $4.10 M(-4.3%) | $15.21 M(+4.6%) |
| June 2021 | $14.55 M(+6.9%) | $4.28 M(+21.4%) | $14.55 M(+1.1%) |
| Mar 2021 | - | $3.53 M(+6.8%) | $14.39 M(+2.8%) |
| Dec 2020 | - | $3.30 M(-3.8%) | $14.00 M(+2.2%) |
| Sept 2020 | - | $3.44 M(-16.7%) | $13.71 M(+0.6%) |
| June 2020 | $13.62 M(+5.9%) | $4.13 M(+31.7%) | $13.62 M(+4.7%) |
| Mar 2020 | - | $3.13 M(+4.2%) | $13.00 M(+0.2%) |
| Dec 2019 | - | $3.01 M(-10.2%) | $12.98 M(-0.1%) |
| Sept 2019 | - | $3.35 M(-4.7%) | $12.99 M(+1.0%) |
| June 2019 | $12.86 M(-10.6%) | $3.51 M(+13.0%) | $12.86 M(+1.1%) |
| Mar 2019 | - | $3.11 M(+2.9%) | $12.71 M(-6.2%) |
| Dec 2018 | - | $3.02 M(-5.9%) | $13.55 M(-2.5%) |
| Sept 2018 | - | $3.21 M(-4.6%) | $13.90 M(-3.4%) |
| June 2018 | $14.39 M(+26.7%) | $3.37 M(-14.6%) | $14.39 M(+3.8%) |
| Mar 2018 | - | $3.95 M(+17.2%) | $13.87 M(+8.0%) |
| Dec 2017 | - | $3.37 M(-9.1%) | $12.84 M(+5.1%) |
| Sept 2017 | - | $3.71 M(+30.2%) | $12.21 M(+7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | $11.35 M(+12.7%) | $2.85 M(-2.5%) | $11.35 M(+4.5%) |
| Mar 2017 | - | $2.92 M(+6.6%) | $10.87 M(+5.4%) |
| Dec 2016 | - | $2.74 M(-3.7%) | $10.31 M(+6.4%) |
| Sept 2016 | - | $2.85 M(+20.7%) | $9.68 M(+0.6%) |
| June 2016 | $10.07 M(+14.9%) | $2.36 M(-0.2%) | $9.62 M(-2.5%) |
| Mar 2016 | - | $2.36 M(+11.6%) | $9.87 M(-2.1%) |
| Dec 2015 | - | $2.12 M(-24.1%) | $10.07 M(+2.0%) |
| Sept 2015 | - | $2.79 M(+7.2%) | $9.87 M(+12.6%) |
| June 2015 | $8.77 M(+69.2%) | $2.60 M(+1.1%) | $8.77 M(+9.4%) |
| Mar 2015 | - | $2.57 M(+34.2%) | $8.02 M(+17.7%) |
| Dec 2014 | - | $1.92 M(+14.0%) | $6.81 M(+11.9%) |
| Sept 2014 | - | $1.68 M(-9.0%) | $6.08 M(+17.4%) |
| June 2014 | $5.18 M(+269.4%) | $1.85 M(+35.4%) | $5.18 M(+37.6%) |
| Mar 2014 | - | $1.36 M(+14.6%) | $3.77 M(+38.2%) |
| Dec 2013 | - | $1.19 M(+52.4%) | $2.73 M(+43.1%) |
| Sept 2013 | - | $781.00 K(+81.2%) | $1.90 M(+35.7%) |
| June 2013 | $1.40 M(+78.3%) | $431.00 K(+33.4%) | $1.40 M(+44.3%) |
| Mar 2013 | - | $323.00 K(-12.5%) | $972.00 K(+49.8%) |
| Dec 2012 | - | $369.00 K(+31.8%) | $649.00 K(+131.8%) |
| Sept 2012 | - | $280.00 K | $280.00 K |
| June 2012 | $787.00 K | - | - |
FAQ
- What is Applied Genetic Technologies annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Applied Genetic Technologies?
- What is Applied Genetic Technologies quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Applied Genetic Technologies?
- What is Applied Genetic Technologies TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Applied Genetic Technologies?
What is Applied Genetic Technologies annual selling, general & administrative expenses?
The current annual SG&A of AGTC is $16.98 M
What is the all time high annual SG&A for Applied Genetic Technologies?
Applied Genetic Technologies all-time high annual selling, general & administrative expenses is $16.98 M
What is Applied Genetic Technologies quarterly selling, general & administrative expenses?
The current quarterly SG&A of AGTC is $4.46 M
What is the all time high quarterly SG&A for Applied Genetic Technologies?
Applied Genetic Technologies all-time high quarterly selling, general & administrative expenses is $4.47 M
What is Applied Genetic Technologies TTM selling, general & administrative expenses?
The current TTM SG&A of AGTC is -$1.20 B
What is the all time high TTM SG&A for Applied Genetic Technologies?
Applied Genetic Technologies all-time high TTM selling, general & administrative expenses is $17.34 M